Publications

Sort by: Date | Author | Title

Ceballos-Baumann, A. O., Sheean, G., Passingham, R. E., Marsden, C. D. & Brooks, D. J. (1997). Botulinum toxin does not reverse the cortical dysfunction associated with writer's cramp. A PET study. Brain, 120(4), 571-582. https://doi.org/10.1093/brain/120.4.571

Ceballos-Baumann, A. O. & Brooks, D. J. (1998). Activation positron emission tomography scanning in dystonia. Advances in neurology, 78, 135-152.

Ceballos-Baumann, A. O. & Brooks, D. J. (1997). Basal ganglia function and dysfunction revealed by PET activation studies. Advances in neurology, 74, 127-139.

Carboncini, M. C., Manzoni, D., Strambi, S., Bonuccelli, U., Pavese, N., Andre, P. & Rossi, B. (2001). The relation between EMG activity and kinematic parameters strongly supports a role of the action tremor in parkinsonian bradykinesia. Movement Disorders, 16(1), 47-57. https://doi.org/10.1002/1531-8257(200101)16:1<47::AID-MDS1012>3.0.CO;2-V

Capaday, C., Richardson, M. P., Rothwell, J. C. & Brooks, D. J. (2000). Long-term changes of GABAergic function in the sensorimotor cortex of amputees. A combined magnetic stimulation and ¹¹C-flumazenil PET study. Experimental Brain Research, 133(4), 552-556. https://doi.org/10.1007/s002210000477

Campbell-Meiklejohn, D., Simonsen, A., Scheel-Krüger, J., Wohlert, V., Gjerløff, T., Frith, C. D., Roepstorff, A., Rogers, R. & Møller, A. (2012). In for a penny, in for a pound: methylphenidate reduces the inhibiting effect of high stakes on persistent risky decisions in healthy adults. Journal of Neuroscience, 32(38), 13032. https://doi.org/10.1523/JNEUROSCI.0151-12.2012

Campbell-Meiklejohn, D., Simonsen, A., Jensen, M., Wohlert, V., Gjerløff, T., Scheel-Krüger, J., Møller, A., Frith, C. D. & Roepstorff, A. (2011). Pharmacology of social conformity: A role for catecholamines. Poster session presented at Neuroscience.

Campbell-Meiklejohn, D., Scheel-Krüger, J., Simonsen, A., Jensen, M., Gjerløff, T., Roepstorff, A., Møller, A. & Frith, C. D. (2011). Pharmacology of social conformity. Poster session presented at The Social Brain, Cambridge, United Kingdom.

Campbell-Meiklejohn, D., Simonsen, A., Jensen, M., Wohlert, V., Gjerløff, T., Scheel-Kruger, J., Møller, A., Frith, C. D. & Roepstorff, A. (2012). Modulation of Social Influence by Methylphenidate. Neuropsychopharmacology. https://doi.org/10.1038/npp.2011.337

Callesen, M. B., Thomsen, K. R., Linnet, J. & Møller, A. (2007). The Gambling Reducing Slot Machine. In Sixth Annual OAK Meeting for Danish Brain Research Laboratories

Callesen, M. B., Linnet, J., Thomsen, K. R., Gjedde, A. & Møller, A. (2008). Pathological Gambling in Parkinson's Disease. Abstract from Seventh Annual OAK Meeting for Danish Brain Research Laboratories, Odense, Denmark.

Callesen, M. B. & Møller, A. (2009). Parkinsons sygdom og ludomani. Parkinson Nyt, 29(1), 10-11.

Callesen, M. B., Scheel-Krüger, J., Kringelbach, M. L. & Møller, A. (2013). A Systematic Review of Impulse Control Disorders in Parkinson's Disease. Journal of Parkinson's Disease, 3(2), 105-138. https://doi.org/10.3233/JPD-120165

Callesen, M. B., Hansen, K. V., Gjedde, A., Linnet, J. & Møller, A. (2013). Dopaminergic and clinical correlates of pathological gambling in Parkinson's disease: A case report. Frontiers in Behavioral Neuroscience, 7(95), 1-8. https://doi.org/10.3389/fnbeh.2013.00095

Callesen, M. B., Weintraub, D., Damholdt, M. F. & Møller, A. (2014). Impulsive and compulsive behaviors among Danish patients with Parkinson’s diseass: Prevalence, depression, and personality. Parkinsonism & Related Disorders, 20(1), 22-26. https://doi.org/10.1016/j.parkreldis.2013.09.006

Callesen, M. B., Weintraub, D., Damholdt, M. F. & Møller, A. (2013). Prevalence of impulse control disorders in Danish patients with Parkinson's disease. Movement Disorders, 28(Suppl 1), 347. http://www.mdsabstracts.com/default.asp

Callesen, M. B., Rømer Thomsen, K., Linnet, J. & Møller, A. (2007). Pathological Gambling Behavior on Slot Machines. Poster session presented at 8th Annual NCRG Conference on Gambling and Addiction, United States.

Callesen, M. B., Weintraub, D., Damholdt, M. F. & Møller, A. (2013). Prevalence of Impulse Control Disorders in Danish Patients with Parkinson's Disease.

Cai, X. L., Xie, D. J., Madsen, K. H., Wang, Y. M., Bögemann, S. A., Cheung, E. F. C., Møller, A. & Chan, R. C. K. (2020). Generalizability of machine learning for classification of schizophrenia based on resting-state functional MRI data. Human Brain Mapping, 41(1), 172-184. https://doi.org/10.1002/hbm.24797

Cai, X. L., Wang, Y. M., Wang, Y., Zhou, H. Y., Huang, J., Wang, Y., Lui, S. S. Y., Møller, A., Hung, K. S. Y., Mak, H. K. F., Sham, P. C., Cheung, E. F. C. & Chan, R. C. K. (2021). Neurological Soft Signs Are Associated with Altered Cerebellar-Cerebral Functional Connectivity in Schizophrenia. Schizophrenia Bulletin, 47(5), 1452-1462. https://doi.org/10.1093/schbul/sbaa200

Cai, X. L., Pu, C. C., Zhou, S. Z., Wang, Y., Huang, J., Lui, S. S. Y., Moller, A., Cheung, E. F. C., Madsen, K. H., Xue, R., Yu, X. & Chan, R. C. K. (2023). Anterior cingulate glutamate levels associate with functional activation and connectivity during sensory integration in schizophrenia: a multimodal ¹H-MRS and fMRI study. Psychological Medicine, 53(11), 4904-4914. https://doi.org/10.1017/S0033291722001817

Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T. & Banati, R. B. (2001). In-vivo measurement of activated microglia in dementia. Lancet, 358(9280), 461-467. https://doi.org/10.1016/S0140-6736(01)05625-2

Burn, D. J., Rinne, J. O., Quinn, N. P., Lees, A. J., Marsden, C. D. & Brooks, D. J. (1995). Striatal opioid receptor binding in parkinson's disease, striatonigral degeneration and steele-richardson-olszewski syndrome: A [¹¹c]diprenorphine PET study. Brain, 118(4), 951-958. https://doi.org/10.1093/brain/118.4.951

Burn, D. J., Sawle, G. V. & Brooks, D. J. (1994). Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: Discriminant analysis of striatal ¹⁸F-dopa PET data. Journal of Neurology Neurosurgery and Psychiatry, 57(3), 278-284. https://doi.org/10.1136/jnnp.57.3.278

Buckley, C. J., Sherwin, P. F., Smith, A. P. L., Wolber, J., Weick, S. M. & Brooks, D. J. (2017). Validation of an electronic image reader training programme for interpretation of [F-18]flutemetamol beta- amyloid PET brain images. Nuclear Medicine Communications, 38(3), 234-241. https://doi.org/10.1097/MNM.0000000000000633

Brunt, E. R., Brooks, D. J., Korczyn, A. D., Montastruc, J. L. & Stocchi, F. (2002). A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa. Journal of Neural Transmission, 109(4), 489-502. https://doi.org/10.1007/s007020200040

Brundin, P., Pogarell, O., Hagell, P., Piccini, P., Widner, H., Schrag, A., Kupsch, A., Crabb, L., Odin, P., Gustavii, B., Björklund, A., Brooks, D. J., Marsden, C. D., Oertel, W. H., Quinn, N. P., Rehncrona, S. & Lindvall, O. (2000). Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain, 123(7), 1380-1390.

Brooks, D. J. (2012). Can imaging separate multiple system atrophy from Parkinson's disease? Movement Disorders, 27(1), 3-5. https://doi.org/10.1002/mds.24046

Brooks, D. J. (2012). Parkinson's disease: diagnosis. Parkinsonism & Related Disorders, 18 Suppl 1, S31-3. https://doi.org/10.1016/S1353-8020(11)70012-8

Brooks, D. J. & Pavese, N. (2011). Imaging biomarkers in Parkinson's disease. Progress in Neurobiology, 95(4), 614-28. https://doi.org/10.1016/j.pneurobio.2011.08.009

Brooks, D. J. (2016). Molecular imaging of dopamine transporters. Ageing Research Reviews, 30, 114-121. https://doi.org/10.1016/j.arr.2015.12.009

Brooks, D. J. & Tambasco, N. (2016). Imaging Synucleinopathies. Movement Disorders, 31(6), 814-829. https://doi.org/10.1002/mds.26547

Brooks, D. J. & Pavese, N. (2010). Imaging non-motor aspects of Parkinson's disease. In Imaging non-motor aspects of Parkinson's disease (Vol. 184, pp. 205-18) https://doi.org/10.1016/S0079-6123(10)84011-7

Brooks, D. J. (2011). Imaging Inflammation in Parkinsonian Syndromes. In Imaging in Parkinson's Disease Oxford University Press. https://doi.org/10.1093/acprof:oso/9780195393484.003.0089

Brooks, D. J. (2010). Examining Braak's hypothesis by imaging Parkinson's disease. Movement Disorders, 25(SUPPL. 1). https://doi.org/10.1002/mds.22720

Brooks, D. J. (2010). Imaging dopamine transporters in Parkinsons disease. Biomarkers in Medicine, 4(5), 651-660. https://doi.org/10.2217/bmm.10.86

Brooks, D. J. (2010). Imaging approaches to Parkinson disease. Journal of Nuclear Medicine, 51(4), 596-609. https://doi.org/10.2967/jnumed.108.059998

Brooks, D. J., Papapetropoulos, S., Vandenhende, F., Tomic, D., He, P., Coppell, A. & O'Neill, G. (2010). An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers. Clinical Neuropharmacology, 33(2), 55-60. https://doi.org/10.1097/WNF.0b013e3181d137d2

Brooks, D. J. & Pavese, N. (2010). Continuous dopaminergic stimulation in Parkinson's disease - What have we learned from positron-emission tomography? European Neurological Review, 5(1), 22-25. https://doi.org/10.17925/ENR.2010.05.01.22

Brooks, D. J. (2009). Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography. Movement Disorders, 24(SUPPL. 2). https://doi.org/10.1002/mds.22581

Brooks, D. J. & Seppi, K. (2009). Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Movement Disorders, 24(7), 949-964. https://doi.org/10.1002/mds.22413

Brooks, D. J. (2008). The role of structural and functional imaging in Parkinsonian states with a description of PET technology. Seminars in Neurology, 28(4), 435-445. https://doi.org/10.1055/s-0028-1083690

Brooks, D. J. (2008). Dopaminergic action beyond its effect on motor function: Imaging studies (Journal of Neurology (2006) 253, Suppl. 4, (IV/8-IV/15) DOI: 10.1007/s00415-006-4003-5). https://doi.org/10.1007/s00415-008-0082-9

Brooks, D. J., Leinonen, M., Kuoppamäki, M. & Nissinen, H. (2008). Five-year efficacy and safety of levodopa/DDCI and entacapone in patients with Parkinson's disease. Journal of Neural Transmission, 115(6), 843-849. https://doi.org/10.1007/s00702-008-0025-8

Brooks, D. J. (2008). Technology Insight: Imaging neurodegeneration in Parkinson's disease. Nature Clinical Practice Neurology, 4(5), 267-277. https://doi.org/10.1038/ncpneuro0773

Brooks, D. J. (2007). Imaging non-dopaminergic function in Parkinson's disease. Molecular Imaging and Biology, 9(4), 217-222. https://doi.org/10.1007/s11307-007-0084-5

Brooks, D. J. (2006). Imaging the role of dopamine in health and disease Parkinson's disease as a lesion model. In Imaging the role of dopamine in health and disease Parkinson's disease as a lesion model (19-20 ed., Vol. 118, pp. 570-572) https://doi.org/10.1007/s00508-006-0737-4

Brooks, D. J., Agid, Y., Eggert, K., Widner, H., Østergaard, K. & Holopainen, A. (2005). Treatment of end-of-dose wearing-off in Parkinson's disease: Stalevo® (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess®/Comtan® (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment. European Neurology, 53(4), 197-202. https://doi.org/10.1159/000086479

Brooks, D. J. & Sagar, H. (2003). Entacapone is beneficial in both fluctuating and non-fluctuating patients with Parkinson's disease: A randomised, placebo controlled, double blind, six month study. Journal of Neurology Neurosurgery and Psychiatry, 74(8), 1071-1079. https://doi.org/10.1136/jnnp.74.8.1071

Brooks, D. J. & Piccini, P. (2006). Imaging in Parkinson's Disease: The Role of Monoamines in Behavior. Biological Psychiatry, 59(10), 908-918. https://doi.org/10.1016/j.biopsych.2005.12.017

Brooks, D. J. (2006). Dopaminergic action beyond its effects on motor function: Imaging studies. In Dopaminergic action beyond its effects on motor function (SUPPL. 4 ed., Vol. 253) https://doi.org/10.1007/s00415-006-4003-5

Brooks, D. J. & Lammertsma, A. A. (2005). Imaging studies in drug development: Parkinson's disease. Drug Discovery Today: Technologies, 2(4), 317-321. https://doi.org/10.1016/j.ddtec.2005.11.001

Brooks, D. J. (2004). Neuroimaging in Parkinson's Disease. NeuroRx, 1(2), 243-254. https://doi.org/10.1602/neurorx.1.2.243

Brooks, D. J., Frey, K. A., Marek, K. L., Oakes, D., Paty, D., Prentice, R., Shults, C. W. & Stoessl, A. J. (2003). Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Experimental Neurology, 184(SUPPL. 1). https://doi.org/10.1016/j.expneurol.2003.08.008

Brooks, D. J., Koller, Olanow, Hauser, Reinikainen, Poewe, Hubble & Stocchi (2004). Safety and tolerability of COMT inhibitors. Neurology, 62(1 SUPPL. 1).

Brooks, D. J. (2003). PET studies on the function of dopamine in health and Parkinson's disease. Annals of the New York Academy of Sciences, 991, 22-35.

Brooks, D. J. (2001). Functional imaging studies on dopamine and motor control. Journal of Neural Transmission, 108(11), 1283-1298. https://doi.org/10.1007/s007020100005

Brooks, D. J. (2002). Diagnosis and management of atypical Parkinsonian syndromes. Neurology in Practice, 72(1).

Brooks, D. J. (2000). Imaging basal ganglia function. Journal of Anatomy, 196(4), 543-554. https://doi.org/10.1017/S0021878299005993

Brooks, D. J. & Piccini, P. (2000). Non-invasive in vivo imaging of transplant function. In Progress in Brain Research (Vol. 127, pp. 321-332) https://doi.org/10.1016/S0079-6123(00)27015-5

Brooks, D. J. & Samuel, M. (2000). The effects of surgical treatment of Parkinson's disease on brain function: PET findings. Neurology, 55(12 SUPPL. 6).

Brooks, D. J. (2000). PET studies and motor complications in Parkinson's disease. Trends in Neurosciences, 23(10 SUPPL.). https://doi.org/10.1016/S1471-1931(00)00016-1

Brooks, D. J. (2000). Dopamine agonists: Their role in the treatment of Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 68(6), 685-689. https://doi.org/10.1136/jnnp.68.6.685

Brooks, D. J. (2000). Functional imaging studies in corticobasal degeneration. Advances in neurology, 82, 209-215.

Brooks, D. J. (2000). Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease. Journal of Neurology, Supplement, 247(2), 11-18.

Brooks, D. J. (1999). Functional imaging of Parkinson's disease: Is it possible to detect brain areas for specific symptoms. Journal of Neural Transmission, Supplement, (56), 139-153.

Brooks, D. J. (2000). Monitoring neuroprotection and restorative therapies in Parkinson's disease with PET. Journal of Neural Transmission, Supplement, (60), 125-137.

Brooks, D. J., Piccini, P., Turjanski, N. & Samuel, M. (2000). Neuroimaging of dyskinesia. Annals of Neurology, 47(4 SUPPL. 1).

Brooks, D. J., Abbott, R. J., Lees, A. J., Martignoni, E., Philcox, D. V., Rascol, O., Roos, R. A. C. & Sagar, H. J. (1998). A placebo-controlled evaluation of ropinirole, a novel D₂ agonist, as sole dopaminergic therapy in Parkinson's disease. Clinical Neuropharmacology, 21(2), 101-107.

Brooks, D. J. (1995). Parkinson's disease-a single clinical entity? QUARTERLY JOURNAL OF MEDICINE, 88(2), 81-91.

Brooks, D. J., Salmon, E. P., Mathias, C. J., Quinn, N., Leenders, K. L., Bannister, R., Marsden, C. D. & Frackowiak, R. S. J. (1990). The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and parkinson's disease, studied with pet. Brain, 113(5), 1539-1552. https://doi.org/10.1093/brain/113.5.1539

Brooks, D. J., Luthert, P., Gadian, D. & Marsden, C. D. (1989). Does signal-attenuation of high-field T₂-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T₂ values and iron levels. Journal of Neurology Neurosurgery and Psychiatry, 52(1), 108-111. https://doi.org/10.1136/jnnp.52.1.108

Brooks, D. J. (1995). The role of the basal ganglia in motor control: contributions from PET. Journal of the Neurological Sciences, 128(1), 1-13. https://doi.org/10.1016/0022-510X(94)00206-4

Brooks, D. J., Turjanski, N., Sawle, G. V., Playford, E. D. & Lees, A. J. (1992). PET studies on the integrity of the pre and postsynaptic dopaminergic system in Tourette syndrome. Advances in neurology, 58, 227-231.

Brooks, D. J., Beaney, R. P., Lammertsma, A. A., Herold, S., Turton, D. R., Luthra, S. K., Frackowiak, R. S., Thomas, D. G., Marshall, J. & Jones, T. (1986). Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [¹¹C]3-O-methyl-D-glucose and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 6(2), 230-239. https://doi.org/10.1038/jcbfm.1986.36

Brooks, D. J., Beaney, R. P., Thomas, D. G. T., Marshall, J. & Jones, T. (1986). Studies on regional cerebral pH in patients with cerebral tumours using continuous inhalation of ¹¹CO₂ and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 6(5), 529-535. https://doi.org/10.1038/jcbfm.1986.98

Brooks, D. J., Gibbs, J. S. R., Sharp, P., Herold, S., Turton, D. R., Luthra, S. K., Kohner, E. M., Bloom, S. R. & Jones, T. (1986). Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [¹¹C]3-O-methyl-D-glucose and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 6(2), 240-244. https://doi.org/10.1038/jcbfm.1986.37

Brooks, D. J., Beaney, R. P., Powell, M., Leenders, K. L., Crockard, H. A., Thomas, D. G. T., Marshall, J. & Jones, T. (1986). Studies on cerebral oxygen metabolism, blood flow, and blood volume, in patients with hydrocephalus before and after surgical decompression, using positron emission tomography. Brain, 109(4), 613-628. https://doi.org/10.1093/brain/109.4.613

Brooks, D. J. (1998). The early diagnosis of Parkinson's disease. Annals of Neurology, 44(3 SUPPL. 1).

Brooks, D. J. (1997). Advances in imaging Parkinson's disease. Current Opinion in Neurology, 10(4), 327-331. https://doi.org/10.1097/00019052-199708000-00008

Brooks, D. J. (1996). Basal ganglia function during normal and parkinsonian movement. PET activation studies. Advances in neurology, 69, 433-441.

Brooks, D. J., Beaney, R. P., Lammertsma, A. A., Turton, D. R., Marshall, J., Thomas, D. G. T. & Jones, T. (1986). Studies on regional cerebral haematocrit and blood flow in patients with cerebral tumours using positron emission tomography. Microvascular Research, 31(3), 267-276. https://doi.org/10.1016/0026-2862(86)90016-6

Brooks, D. J., Lammertsma, A. A., Beaney, R. P., Leenders, K. L., Buckingham, P. D., Marshall, J. & Jones, T. (1984). Measurement of regional cerebral pH in human subjects using continuous inhalation of ¹¹CO₂ and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 4(3), 458-465. https://doi.org/10.1038/jcbfm.1984.65

Brooks, D. J., Beaney, R. P., Lammertsma, A. A., Leenders, K. L., Horlock, P. L., Kensett, M. J., Marshall, J., Thomas, D. G. & Jones, T. (1984). Quantitative measurement of blood-brain barrier permeability using rubidium-82 and positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 4(4), 535-545. https://doi.org/10.1038/jcbfm.1984.78

Brooks, D. J. (1993). Functional imaging in relation to parkinsonian syndromes. Journal of the Neurological Sciences, 115(1), 1-17. https://doi.org/10.1016/0022-510X(93)90061-3

Brooks, D. J., Carr, D. H. & Legg, N. J. (1987). The role of delayed computed tomographic scanning using high dose of contrast material in detecting cerebral demyelination in patients with multiple sclerosis in relapse and remission. British Journal of Radiology, 60(711), 295-297. https://doi.org/10.1259/0007-1285-60-711-295

Brooks, D. J. (1989). Positron emission tomographic studies of the subcortical degenerations and dystonia. Seminars in Neurology, 9(4), 351-359. https://doi.org/10.1055/s-2008-1041345

Brooks, D. J. (1991). PET: Its clinical role in neurology. Journal of Neurology Neurosurgery and Psychiatry, 54(1), 1-5. https://doi.org/10.1136/jnnp.54.1.1

Brooks, D. J. (1998). Positron emission tomography studies in movement disorders. Neurosurgery Clinics of North America, 9(2), 263-281.

Brooks, D. J. (1997). PET and SPECT studies in Parkinson's disease. Bailliere's Clinical Neurology, 6(1), 69-87.

Brooks, D. J. (1994). PET studies in progressive supranuclear palsy. Journal of Neural Transmission, Supplement, (42), 119-134.

Brooks, D. J. (1996). Functional imaging techniques in the diagnosis of non-Alzheimer dementias. Journal of Neural Transmission, Supplement, (47), 155-167.

Brooks, D. J. (1993). PET studies on the early and differential diagnosis of Parkinson's disease. Neurology, 43(12 II SUPPL. 6).

Brooks, D. J., Torjanski, N. & Burn, D. J. (1995). Ropinirole in the symptomatic treatment of Parkinson's disease. Journal of Neural Transmission, Supplement, (45), 231-238.

Brooks, D. J., Beaney, R. P. & Thomas, D. G. T. (1986). The role of Positron Emission Tomography in the study of cerebral tumors. Seminars in Oncology, 13(1), 83-93.

Brooks, D. J. (1991). Detection of preclinical Parkinson's disease with PET. Geriatrics, 46 Suppl 1, 25-30.

Brooks, D. J. (1992). PET: Motor function and dysfunction. Movement Disorders, 7(1 S), 20. https://doi.org/10.1002/mds.870070521

Brooks, D. J. (1991). The clinical role of PET in cerebrovascular disease. Neurosurgical Review, 14(2), 91-96. https://doi.org/10.1007/BF00313030

Brooks, D. J. (2016). Imaging of genetic and degenerative disorders primarily causing Parkinsonism. In R. G. Gonzalez & J. C. Masdeu (Eds.), Neuroimaging Part I, 2016 (pp. 493-505). Elsevier B.V. https://doi.org/10.1016/B978-0-444-53485-9.00024-6

Brooks, D. J. (2021). Imaging Familial and Sporadic Neurodegenerative Disorders Associated with Parkinsonism. Neurotherapeutics, 18(2), 753-771. https://doi.org/10.1007/s13311-020-00994-4

Brooks, D. J. (2021). Future Imaging in Dementia. Seminars in Nuclear Medicine, 51(3), 303-308. https://doi.org/10.1053/j.semnuclmed.2020.12.001

Bro, A., Sørensen, J. C. H., Nielsen, M. S., Rosendahl, F., Deding, D., Ettrup, K. S., Jensen, K. N., Jørgensen, R. L., Glud, A. N., Meidahl, A. C. N., Meier, K., Moberg Fitting, L., Møller, A., Alstrup, A. K. O., Østergaard, L. & Bjarkam, C. R. (2012). The Göttingen minipig in translational neuroscience. Ellegaard Newsletter, 38, 8-9.

Brett, M., Stein, J. F. & Brooks, D. J. (1998). The role of the lateral premotor cortex in conditional and imitated praxis. NeuroImage, 7(4 PART II).

Brett, M., Jenkins, I. H., Stein, J. F. & Brooks, D. J. (1997). Movement selection without preparation does not activate the SMA. NeuroImage, 5(4 PART II).

Breen, D. P., Nombela, C., Vuono, R., Jones, P. S., Fisher, K., Burn, D. J., Brooks, D. J., Reddy, A. B., Rowe, J. B. & Barker, R. A. (2016). Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease. Movement Disorders, 31(7), 1062-1066. https://doi.org/10.1002/mds.26592

Botzel, K., Schulze, S., Jahanshahi, M., Jenkins, H., Brown, R. G., Marsden, C. D., Passingham, R. E. & Brooks, D. J. (1996). Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects [1]. Brain, 119(3), 1045-1048. https://doi.org/10.1093/brain/119.3.1045

Borghammer, P., Knudsen, K., Østergaard, K., Danielsen, E. H., Pavese, N., Arveschoug, A., Bluhme, H., Bode, M. & Morsing, A. (2014). Combined DaT imaging and olfactory testing for differentiating parkinsonian disorders. International Journal of Clinical Practice, 68(11), 1345-51. https://doi.org/10.1111/ijcp.12445

Borghammer, P., Knudsen, K. & Brooks, D. J. (2016). Imaging Systemic Dysfunction in Parkinson's Disease. Current Neurology and Neuroscience Reports, 16(6), 51. Article 51. https://doi.org/10.1007/s11910-016-0655-4

Borghammer, P., Knudsen, K., Fedorova, T. D. & Brooks, D. J. (2017). Imaging Parkinson's disease below the neck. npj Parkinson's Disease , 3(1), 15. Article 0017. https://doi.org/10.1038/s41531-017-0017-1

Bonuccelli, U. & Pavese, N. (2007). Role of dopamine agonists in Parkinson's disease: An update. Expert Review of Neurotherapeutics, 7(10), 1391-1399. https://doi.org/10.1586/14737175.7.10.1391

Bonuccelli, U. & Pavese, N. (2006). Dopamine agonists in the treatment of Parkinson's disease. Expert Review of Neurotherapeutics, 6(1), 81-89. https://doi.org/10.1586/14737175.6.1.81

Bonuccelli, U., Pavese, N., Lucetti, C., Renna, M. R., Gambaccini, G., Bernardini, S., Canapicchi, R., Carrozzi, L. & Murri, L. (1999). Late whiplash syndrome: A clinical and magnetic resonance imaging study. Functional Neurology, 14(4), 219-225.

Bonuccelli, U., D'Avino, C., Caraccio, N., Del Guerra, P., Casolaro, A., Pavese, N., Del Dotto, P. & Monzani, F. (1999). Thyroid function and autoimmunity in Parkinson's disease: A study of 101 patients. Parkinsonism and Related Disorders, 5(1-2), 49-53. https://doi.org/10.1016/S1353-8020(99)00010-3

Bonuccelli, U., Nuti, A., Lucetti, C., Pavese, N., Dell'Agnello, G. & Muratorio, A. (1996). Amitriptyline and dexamethasone combined treatment in drug-induced headache. Cephalalgia, 16(3), 197-200. https://doi.org/10.1046/j.1468-2982.1996.1603197.x

Bonuccelli, U., Piccini, P., Del Dotto, P., Pavese, N., D'Antonio, P. & Muratorio, A. (1992). Apomorphine test in de novo Parkinson's disease. Functional Neurology, 7(4), 295-298.

Boecker, H. & Brooks, D. J. (2011). Resting tremor in Parkinson disease: Is the pallidum to blame? Annals of Neurology, 69(2), 229-231. https://doi.org/10.1002/ana.22358

Boecker, H., Weindl, A., Brooks, D. J., Ceballos-Baumann, A. O., Liedtke, C., Miederer, M., Sprenger, T., Wagner, K. J. & Miederer, I. (2010). GABAergic dysfunction in essential tremor: An¹¹C-flumazenil PET study. Journal of Nuclear Medicine, 51(7), 1030-1035. https://doi.org/10.2967/jnumed.109.074120

Boecker, H., Ceballos-Baumann, A. O., Bartenstein, P., Dagher, A., Forster, K., Haslinger, B., Brooks, D. J., Schwaiger, M. & Conrad, B. (2002). A H₂ ¹⁵O positron emission tomography study on mental imagery of movement sequences - The effect of modulating sequence length and direction. NeuroImage, 17(2), 999-1009. https://doi.org/10.1016/S1053-8119(02)91139-0

Boecker, H., Ceballos-Baumann, A. O., Bartenstein, P., Siebner, H. R., Forster, K., Dagher, A., Haslinger, B., Brooks, D. J. & Conrad, B. (1999). PET imaging of motor sequence control: Pure motor imagination of increasingly complex finger sequences, A parametric 3D H2 15O PET study. NeuroImage, 9(6 PART II).

Boecker, H. & Brooks, D. J. (1998). Functional imaging of tremor. Movement Disorders, 13(SUPPL. 3), 64-72.

Boecker, H., Dagher, A., Ceballos-Baumann, A. O., Passingham, R. E., Samuel, M., Friston, K. J., Poline, J. B., Dettmers, C., Conrad, B. & Brooks, D. J. (1998). Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H₂ ¹⁵O PET. Journal of Neurophysiology, 79(2), 1070-1080. https://doi.org/10.1152/jn.1998.79.2.1070

Boecker, H., Wills, A. J., Ceballos-Baumann, A., Samuel, M., Thomas, D. G. T., Marsden, C. D. & Brooks, D. J. (1997). Stereotactic thalamotomy in tremor-dominant parkinson's disease: An H₂ ¹⁵O PET motor activation study. Annals of Neurology, 41(1), 108-111. https://doi.org/10.1002/ana.410410118

Boecker, H., Wills, A. J., Ceballos-Baumann, A., Samuel, M., Thompson, P. D., Findley, L. J. & Brooks, D. J. (1996). The effect of ethanol on alcohol-responsive essential tremor: A position emission tomography study. Annals of Neurology, 39(5), 650-658. https://doi.org/10.1002/ana.410390515

Boecker, H., Dagher, A., Ceballos-Baumann, A. O., Passingham, R. E., Samuel, M., Friston, K. J., Poline, J. B., Dettmers, C., Conrad, B. & Brooks, D. J. (1998). Erratum: Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: Investigations with H₂ ¹⁵O PET (Journal of Neurophysiology (February 1998) 79 (1070-1080)). Journal of Neurophysiology, 79(4).

Bjarkam, C., Nielsen, M. S., Glud, A. N., Rosendal, F., Mogensen, P., Bender, D., Doudet, D., Møller, A. & Sørensen, J. C. H. (2008). Neuromodulation in a minipig MTTP model of Parkinson disease. British Journal of Neurosurgery, 22/1, 9-12.

Bjarkam, C. R., Nielsen, M. S., GLUD, AN., Rosendal, F., Mogensen, P., Bender, D., Doudet, D., Møller, A. & Sørensen, J. C. (2008). Neuromodulation in a minipig MPTP model of Parkinson disease. British Journal of Neurosurgery, 22 Suppl 1, S9-12. https://doi.org/10.1080/02688690802448285

Binda, K. H., Lillethorup, T. P., Real, C. C., Bærentzen, S. L., Nielsen, M. N., Orlowski, D., Brooks, D. J., Chacur, M. & Landau, A. M. (2021). Exercise protects synaptic density in a rat model of Parkinson's disease. Experimental Neurology, 342, 113741. Article 113741. https://doi.org/10.1016/j.expneurol.2021.113741

Bhatnagar, M., Cintra, A., Chadi, G., Lindberg, J., Oitzl, M., De Kloet, E. R., Møller, A., Agnati, L. F. & Fuxe, K. (1997). Neurochemical changes in the hippocampus of the brown norway rat during aging. Neurobiology of Aging, 18, 319-327.

Bhatia, K., Brooks, D. J., Burn, D. J., Clarke, C. E., Grosset, D. G., MacMahon, D. G., Fer, J. P., Schapira, A. H. V., Stewart, D. & Williams, A. C. (2001). Updated guidelines for the management of Parlcinson's disease. Hospital Medicine, 62(8), 456-470. https://doi.org/10.12968/hosp.2001.62.8.1621

Bhatia, K. P., Turjanski, N., Brooks, D. J., Marsden, C. D. & Thrush, D. (1996). The usefulness of functional imaging in movement disorders: An illustrative case [8]. Journal of Neurology Neurosurgery and Psychiatry, 60(3), 353-354. https://doi.org/10.1136/jnnp.60.3.353

Bhatia, K., Brooks, D. J., Burn, D. J., Clarke, C. E., Playfer, J., Sawle, G. V., Schapira, A. H. V., Stewart, D. & Williams, A. C. (1998). Guidelines for the management of Parkinson's disease. Hospital Medicine, 59(6), 469-480.

Betzer, C., Lassen, L. B., Olsen, A., Kofoed, R. H., Reimer, L., Gregersen, E., Zheng, J., Calì, T., Gai, W.-P., Chen, T., Moeller, A., Brini, M., Fu, Y., Halliday, G., Brudek, T., Aznar, S., Pakkenberg, B., Andersen, J. P. & Jensen, P. H. (2018). Alpha-synuclein aggregates activate calcium pump SERCA leading to calcium dysregulation. EMBO Reports, 19(5), Article e44617. https://doi.org/10.15252/embr.201744617

Best, L., Ghadery, C., Pavese, N., Tai, Y. F. & Strafella, A. P. (2019). New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease. Current Neurology and Neuroscience Reports, 19(5), Article 24. https://doi.org/10.1007/s11910-019-0934-y

Bertelsen, F., Sabers, A., Nyengaard, J. R., Alstrup, A. K. O., Møller, A. & Scheel-Krüger, J. (2011). A new animal model for the fetal valproate syndrome with relevance for epilepsy and autism. Abstract from Tenth annual OAK Meeting, Aarhus C, Denmark.

Bertelsen, F. C. B., Møller, A., Landau, A. M. & Scheel-Krüger, J. (2012). AN ANIMAL MODEL FOR THE FETAL VALPROATE SYNDROME – WITH RELEVANCE TO AUTISM. Abstract from The British Association for Psychopharmacology, Harrogate, United Kingdom.

Bertelsen, F. C. B., Landau, A. M., Scheel-Krüger, J. & Møller, A. (2012). Characterization and further development of an animal model for the fetal Valproate Syndrome – with relevance to autism. Poster session presented at Society For Neuroscience, New Orleans, United States.

Bertelsen, F. C. B., Møller, A., Landau, A. M. & Scheel-Krüger, J. (2012). EN NY DYREMODEL FOR AUTISME. Poster session presented at Psykiatriens Forskningsdag, Risskov, Denmark.

Bertelsen, F. C. B., Møller, A., Landau, A. M. & Scheel-Krüger, J. (2011). A new animal model for the fetal Valproate syndrome. Abstract from Tenth Annual OAK Meeting 2011, Aarhus, Denmark.

Bertelsen, F. C. B., Møller, A., Landau, A. M. & Scheel-Krüger, J. (2012). CHARACTERISATION AND FURTHER DEVELOPMENT OF AN ANIMAL MODEL FOR THE FETAL VALPROATE SYNDROME. Abstract from OAK 2012, Odense, Denmark.

Bertelsen, F. C. B., Møller, A., Landau, A. M. & Scheel-Krüger, J. (2013). AN ANIMAL MODEL FOR THE FETAL VALPROATE SYNDROME: – WITH RELEVANCE TO AUTISM. Poster session presented at The International Meeting for Autism Research (IMFAR) , San Sebastian, Spain.

Bertelsen, F., Møller, A., Folloni, D., Drasbek, K. R., Scheel-Krüger, J. & Landau, A. M. (2017). Increased GABA_A receptor binding in amygdala after prenatal administration of valproic acid to rats. Acta Neuropsychiatrica, 29(5), 309-3014. https://doi.org/10.1017/neu.2016.59

Bertelsen, F., Folloni, D., Møller, A., Landau, A. M., Scheel-Krüger, J. & Winterdahl, M. (2017). Suppressed play behaviour and decreased oxytocin receptor binding in the amygdala after prenatal exposure to low-dose valproic acid. Behavioural Pharmacology, 28(6), 450-457. https://doi.org/10.1097/FBP.0000000000000316

Bertelsen, F., Landau, A. M., Vase, K. H., Jacobsen, J., Scheel-Krüger, J. & Møller, A. (2018). Acute in vivo effect of valproic acid on the GABAergic system in rat brain: A [C-11]Ro15-4513 microPET study. Brain Research, 1680, 110-114. https://doi.org/10.1016/j.brainres.2017.12.018

Berding, G., Odin, P., Brooks, D. J., Nikkhah, G., Matthies, C., Peschel, T., Shing, M., Kolbe, H., van den Hoff, J., Fricke, H., Dengler, R., Samii, M. & Knapp, W. H. (2001). Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [¹⁸F]FDG-PET. Movement Disorders, 16(6), 1014-1022. https://doi.org/10.1002/mds.1212

Berding, G., Brücke, T., Odin, P., Brooks, D. J., Kolbe, H., Gielow, P., Harke, H., Knoop, B. O., Dengler, R. & Knapp, W. H. (2003). [¹²³I]β-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy. Nuklearmedizin, 42(1), 31-38.

Berardelli, A., Wenning, G. K., Antonini, A., Berg, D., Bloem, B. R., Bonifati, V., Brooks, D., Burn, D. J., Colosimo, C., Fanciulli, A., Ferreira, J., Gasser, T., Grandas, F., Kanovsky, P., Kostic, V., Kulisevsky, J., Oertel, W., Poewe, W., Reese, J. P. ... Vidailhet, M. (2013). EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease. European Journal of Neurology, 20(1), 16-34. https://doi.org/10.1111/ene.12022

Bennekou, P., Pedersen, O., Møller, A. & Christophersen, P. (2000). Volume control in sickle cells is facilitated by the novel anion conductance inhibitor NS1652. Blood, 95, 1842-1848.

Bellini, G., Best, L. A., Brechany, U., Mills, R. & Pavese, N. (2020). Clinical Impact of Deep Brain Stimulation on the Autonomic System in Patients with Parkinson's Disease. Movement Disorders Clinical Practice, 7(4), 373-382. https://doi.org/10.1002/mdc3.12938

Beaney, R. P., Brooks, D. J., Leenders, K. L., Thomas, D. G., Jones, T. & Halnan, K. E. (1985). Blood flow and oxygen utilisation in the contralateral cerebral cortex of patients with untreated intracranial tumours as studied by positron emission tomography, with observations on the effect of decompressive surgery. Journal of Neurology Neurosurgery and Psychiatry, 48(4), 310-319. https://doi.org/10.1136/jnnp.48.4.310

Beaney, R. P., Gibbs, J. S. R., Brooks, D. J., McKenzie, C. G., Joplin, G. F. & Jones, T. (1987). Absence of irradiation induced ischaemic temporal lobe damage in patients with pituitary tumours. Journal of Neuro-Oncology, 5(2), 129-137. https://doi.org/10.1007/BF02571301

Barker, R. A., Mason, S. L., Harrower, T. P., Swain, R. A., Ho, A. K., Sahakian, B. J., Mathur, R., Elneil, S., Thornton, S., Hurrelbrink, C., Armstrong, R. J., Tyers, P., Smith, E., Carpenter, A., Piccini, P., Tai, Y. F., Brooks, D. J., Pavese, N., Watts, C. ... NEST-UK collaboration (2013). The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. Journal of Neurology, Neurosurgery & Psychiatry, 84(6), 657-65. https://doi.org/10.1136/jnnp-2012-302441

Bannon, D., Landau, A. M. & Doudet, D. J. (2015). How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease? Current Neurology and Neuroscience Reports, 15(8), 571. https://doi.org/10.1007/s11910-015-0571-z

Banati, R. B., Cagnin, A., Brooks, D. J., Gunn, R. N., Myers, R., Jones, T., Birch, R. & Anand, P. (2001). Long-term trans-synaptic glial responses in the human thalamus after peripheral nerve injury. NeuroReport, 12(16), 3439-3442. https://doi.org/10.1097/00001756-200111160-00012

Banati, R. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F. E., Brooks, D. J. & Jones, T. (2000). Microglial activation in neurodegenerative diseases: A PET study using [¹¹C](R)-PK11195. NeuroImage, 11(6 PART II).

Banati, R. B., Goerres, G. W., Myers, R., Gunn, R. N., Turkheimer, F. E., Kreutzberg, G. W., Brooks, D. J., Jones, T. & Duncan, J. S. (1999). [¹¹C] (R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis. Neurology, 53(9), 2199-2203.

Banati, R. B., Görres, G., Brooks, D. J., Aggleton, J. P. & Grasby, P. M. (1997). The functional anatomy of sensory integration in man. NeuroImage, 5(4 PART II).

Bain, P. G., Britton, T. C., Jenkins, I. H., Thompson, P. D., Rothwell, J. C., Thomas, P. K., Brooks, D. J. & Marsden, C. D. (1996). Tremor associated with benign IgM paraproteinaemic neuropathy. Brain, 119(3), 789-799. https://doi.org/10.1093/brain/119.3.789

Bærentzen, S. L., Thomsen, M., Alstrup, A. K. O., Wegener, G., Brooks, D. J., Winterdahl, M. & Landau, A. (2024). Excessive sucrose consumption reduces synaptic density and increases cannabinoid receptors in Göttingen minipigs. Neuropharmacology, 256, Article 110018. https://doi.org/10.1016/j.neuropharm.2024.110018

Bærentzen, S. L., Thomsen, J. B., Thomsen, M. B., Jakobsen, S., Simonsen, M. T., Wegener, G., Brooks, D. J. & Landau, A. M. (2024). Subanesthetic S-ketamine does not acutely alter striatal dopamine transporter binding in healthy Sprague Dawley female rats. Synapse, 78(4), Article e22294. https://doi.org/10.1002/syn.22294

Bærentzen, S. L., Waszkiewicz, A. L., Thomsen, M., Knudsen, C. M. R., Elfving, B. & Landau, A. (2024). A single subanaesthetic dose of the rapid-acting antidepressant S-ketamine raises presynaptic SV2A density in limbic regions of the Wistar Kyoto rat model of depression. Neuroscience Applied, 3, Article 104079. https://doi.org/10.1016/j.nsa.2024.104079

Ashraf, A., Fan, Z., Brooks, D. J. & Edison, P. (2015). Cortical hypermetabolism in MCI subjects: a compensatory mechanism? European journal of nuclear medicine and molecular imaging, 42(3), 447-458. https://doi.org/10.1007/s00259-014-2919-z

Arshad, Q., Bonsu, A., Lobo, R., Fluri, A.-S., Sheriff, R., Bain, P., Pavese, N. & Bronstein, A. M. (2017). Biased numerical cognition impairs economic decision-making in Parkinson's disease. Annals of clinical and translational neurology, 4(10), 739-748. https://doi.org/10.1002/acn3.449

Arjmand, S., Wegener, G., Landau, A. M. & Eskelund, A. (2022). Tips and traps for behavioural animal experimentation. Acta Neuropsychiatrica, 34(5), 240-252. https://doi.org/10.1017/neu.2022.4

Arjmand, S., Landau, A. M., Varastehmoradi, B., Andreatini, R., Joca, S. & Wegener, G. (2022). The intersection of astrocytes and the endocannabinoid system in the lateral habenula: on the fast-track to novel rapid-acting antidepressants. Molecular Psychiatry, 27(8), 3138–3149 . https://doi.org/10.1038/s41380-022-01598-4

Arjmand, S., Vadstrup Pedersen, M., Silva, N. R., Landau, A. M., Joca, S. & Wegener, G. (2023). Sex and Estrous Cycle Are Not Mediators of S-Ketamine's Rapid-Antidepressant Behavioral Effects in a Genetic Rat Model of Depression. The international journal of neuropsychopharmacology, 26(5), 350–358. https://doi.org/10.1093/ijnp/pyad016

Arjmand, S., Bender, D., Jakobsen, S., Wegener, G. & Landau, A. M. (2023). Peering into the Brain's Estrogen Receptors: PET Tracers for Visualization of Nuclear and Extranuclear Estrogen Receptors in Brain Disorders. Biomolecules, 13(9), Article 1405. https://doi.org/10.3390/biom13091405

Arjmand, S., Ilaghi, M., Sisakht, A. K., Guldager, M. B., Wegener, G., Landau, A. M. & Gjedde, A. (2024). Regulation of mitochondrial dysfunction by estrogens and estrogen receptors in Alzheimer's disease: A focused review. Basic & Clinical Pharmacology & Toxicology, 135(2), 115-132. https://doi.org/10.1111/bcpt.14035

Archer, H. A., Edison, P., Brooks, D. J., Barnes, J., Frost, C., Yeatman, T., Fox, N. C. & Rossor, M. N. (2006). Amyloid load and cerebral atrophy in Alzheimer's disease: An ¹¹C-PIB positron emission tomography study. Annals of Neurology, 60(1), 145-147. https://doi.org/10.1002/ana.20889

Angeles, P., Mace, M., Admiraal, M., Burdet, E., Pavese, N. & Vaidyanathan, R. (2016). A Wearable Automated System to Quantify Parkinsonian Symptoms Enabling Closed Loop Deep Brain Stimulation. In L. Alboul, D. Damian & JM. Aitken (Eds.), Towards Autonomous Robotic Systems - 17th Annual Conference, TAROS 2016, Proceedings (pp. 8-19). SPRINGER INT PUBLISHING AG. https://doi.org/10.1007/978-3-319-40379-3_2

Angeles, P., Tai, Y., Pavese, N., Wilson, S. & Vaidyanathan, R. (2017). Automated assessment of symptom severity changes during deep brain stimulation (DBS) therapy for Parkinson's disease. In 2017 International Conference on Rehabilitation Robotics, ICORR 2017 (Vol. 2017, pp. 1512-1517). Article 8009462 https://doi.org/10.1109/ICORR.2017.8009462

Andrews, T. C., Weeks, R. A., Turjanski, N., Gunn, R. N., Watkins, L. H. A., Sahakian, B., Hodges, J. R., Rosser, A. E., Wood, N. W. & Brooks, D. J. (1999). Huntington's disease progression. PET and clinical observations. Brain, 122(12), 2353-2363. https://doi.org/10.1093/brain/122.12.2353

Andrews, T. C. & Brooks, D. J. (1998). Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET. Molecular medicine today, 4(12), 532-539. https://doi.org/10.1016/S1357-4310(98)01371-9

Anderson, A. N., Pavese, N., Edison, P., Tai, Y. F., Hammers, A., Gerhard, A., Brooks, D. J. & Turkheimer, F. E. (2007). A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195. NeuroImage, 36(1), 28-37. https://doi.org/10.1016/j.neuroimage.2007.02.017

Anderson, T. J., Jenkins, I. H., Brooks, D. J., Hawken, M. B., Frackowiak, R. S. J. & Kennard, C. (1994). Cortical control of saccades and fixation in man A PET study. Brain, 117(5), 1073-1084. https://doi.org/10.1093/brain/117.5.1073

Andersen, B. B., Møller, A., Gram, L., Jensen, N. O. & Dam, M. (1992). Phenytoin-loading: pharmacokinetic comparison between an intravenous bolus injection and a diluted standard solution. Acta Neurology Scand, 85, 174-176.

Andersen, K. B., Hansen, A. K., Sommerauer, M., Fedorova, T. D., Knudsen, K., Vang, K., Van Den Berge, N., Kinnerup, M., Nahimi, A., Pavese, N., Brooks, D. J. & Borghammer, P. (2020). Altered sensorimotor cortex noradrenergic function in idiopathic REM sleep behaviour disorder: A PET study. Parkinsonism & Related Disorders, 75, 63-69. https://doi.org/10.1016/j.parkreldis.2020.05.013

Andersen, K. B., Hansen, A. K., Damholdt, M. F., Horsager, J., Skjaerbaek, C., Gottrup, H., Klit, H., Schacht, A. C., Danielsen, E. H., Brooks, D. J. & Borghammer, P. (2021). Reduced Synaptic Density in Patients with Lewy Body Dementia: An [¹¹C-]UCB-J PET Imaging Study. Movement Disorders, 36(9), 2057-2065. https://doi.org/10.1002/mds.28617

Andersen, K. B., Hansen, A. K., Knudsen, K., Schacht, A. C., Damholdt, M. F., Brooks, D. J. & Borghammer, P. (2022). Healthy brain aging assessed with [¹⁸F]FDG and [¹¹C]UCB-J PET. Nuclear Medicine and Biology, 112-113, 52-58. https://doi.org/10.1016/j.nucmedbio.2022.06.007

Andersen, O. M., Bøgh, N., Landau, A. M., Pløen, G. G., Jensen, A. M. G., Monti, G., Ulhøi, B. P., Nyengaard, J. R., Jacobsen, K. R., Jørgensen, M. M., Holm, I. E., Kristensen, M. L., Alstrup, A. K. O., Hansen, E. S. S., Teunissen, C. E., Breidenbach, L., Droescher, M., Liu, Y., Pedersen, H. S. ... Sørensen, C. B. (2022). A genetically modified minipig model for Alzheimer's disease with SORL1 haploinsufficiency. Cell Reports Medicine, 3(9), Article 100740. https://doi.org/10.1016/j.xcrm.2022.100740

Andersen, K. B., Hansen, A. K., Schacht, A. C., Horsager, J., Gottrup, H., Klit, H., Danielsen, E. H., Poston, K. L., Pavese, N., Brooks, D. J. & Borghammer, P. (2023). Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [¹¹C]UCB-J and [¹⁸F]FDG PET Study. Movement disorders : official journal of the Movement Disorder Society, 38(5), 796-805. https://doi.org/10.1002/mds.29375

Álvarez-Martos, I., Møller, A. & Ferapontova, E. E. (2019). Dopamine Binding and Analysis in Undiluted Human Serum and Blood by the RNA-Aptamer Electrode. ACS Chemical Neuroscience, 10(3), 1706-1715. https://doi.org/10.1021/acschemneuro.8b00616

Alstrup, A. K. O., Jakobsen, S., Wegener, G., Hansen, A. K., Doudet, D. & Landau, A. M. (2010). Anesthesia in animal imaging: Differing effects of propofol versus isoflurane on dopamine 1 receptor binding in Göttingen minipig brain. NeuroImage, (1), 181.

Alstrup, A. K. O. & Landau, A. M. (2010). Pigs in PET: Differing effects of propofol versus isoflurane on dopamine 1 receptor binding in Göttingen minipig brain. Abstract from OAK Meeting, København, Denmark.

Alstrup, A. K. O., Winterdahl, M., Simonsen, M., Jakobsen, S., Møller, A., Scheel-Krüger, J. & Landau, A. M. (2011). Imaging techniques in small and large animals. Abstract from Scandlas Symposium, København, Denmark.

Alstrup, A. K. O., Simonsen, M. & Landau, A. M. (2011). Type of anesthesia influences positron emission tomography measurements of dopamine D2/3 receptor binding in the rat brain. Scand J Lab Anim Sci, 38(3), 195-200.

Alstrup, A. K. O., Simonsen, M. & Landau, A. M. (2011). Type of anesthesia is important in rodent microPET studies: Effects of fentanyl-fluanisone-midazolam and isoflurane on measurements of dopamine D2/3 receptor binding in the rat brain. Poster session presented at ScandLAS Symposiet, Århus, Denmark.

Alstrup, A. K. O., Simonsen, M., Møller, A. & Landau, A. M. (2011). Effects of anesthesia on [11C]raclopride binding in the rat brain. Abstract from OAK Meeting, Århus, Denmark.

Alstrup, A. K. O., Landau, A. M., Holden, J. E., Simonsen, M., Schacht, A. C., Jakobsen, S., Wegener, G., Hansen, A. K., Gjedde, A. & Doudet, D. (2011). On the interpretation of PET binding data in brain: Effects of anesthesia and consideration of species differences. Abstract from World Molecular Imaging Congress (WMIC), San Diego, United States.

Alstrup, A. K. O., Landau, A. M., Møller, A., Simonsen, M., Jakobsen, S., Audrain, H., Videbech, P., Wegener, G., Gjedde, A. & Doudet, D. (2011). Elektrochok påvirker hjernens dopamin- og noradrenalin receptor-binding hos Göttingen minigrise. Poster session presented at Psykiatriens Forskningsdag.

Alstrup, A. K. O., Landau, A. M., Winterdahl, M., Zeidler, D., Jensen, S. B., Munk, O. L. & Sørensen, J. C. H. (2015). Imaging Techniques with CT, MRI, PET, and SPECT. In Swine in the laboratory CRC Press Inc..

Alstrup, A. K. O., Landau, A. M., Holden, J. E., Jakobsen, S., Schacht, A. C. S., Audrain, H., Wegener, G., Hansen, A. K., Gjedde, A. & Doudet, D. (2013). Effects of anesthesia and species on the uptake or binding of radioligands in vivo in the Göttingen minipig. BioMed Research International, 2013(808713), 1-9.

Alstrup, A. K. O., Winterdahl, M. & Landau, A. M. (2013). MPTP and other minipig models of Parkinson’s disease. Abstract from Minipig Research Forum, Rom, Italy.

Alstrup, A. K. O., Munk, O. L., Landau, A. M. & Lillethorup, T. P. (2018). PET radioligand injection for pig neuroimaging. Scandinavian Journal of Laboratory Animal Science, 44(2), 1-5.

Alstrup, A. K. O., Lillethorup, T. P., Landau, A. & Afzelius, P. (2024). The arterial blood sampling associated with PET imaging studies can lead to post-scan complications in Göttingen minipigs. Scandinavian Journal of Laboratory Animal Science, 50(2), 6-12. https://doi.org/10.23675/sjlas.v50i.22397

Al-Aish, M., Coleman, R. E., Larson, S. M., Barrio, J., Brodack, J., Brooks, D., Di Chiro, G., Eckelman, W., Fowler, J., Frost, J., Gould, K. L., Krohn, K., Kuhl, D., Marcus, C. S., Martin, W., Mazziotta, J., Mintun, M., Muehllehner, G. & Mullani, N. (1990). National cancer institute workshop statement. Advances in clinical imaging using positron emission tomography, September 14-16, 1988. Archives of Internal Medicine, 150(4), 735-739. https://doi.org/10.1001/archinte.150.4.735

Al-Absi, A.-R., Thambiappa, S. K., Khan, A. R., Glerup, S., Sanchez, C., Landau, A. M. & Nyengaard, J. R. (2022). Df(h22q11)/+ mouse model exhibits reduced binding levels of GABA_A receptors and structural and functional dysregulation in the inhibitory and excitatory networks of hippocampus. Molecular and Cellular Neuroscience, 122, Article 103769. https://doi.org/10.1016/j.mcn.2022.103769

Ahsan, R. L., Allom, R., Gousias, I. S., Habib, H., Turkheimer, F. E., Free, S., Lemieux, L., Myers, R., Duncan, J. S., Brooks, D. J., Koepp, M. J. & Hammers, A. (2007). Volumes, spatial extents and a probabilistic atlas of the human basal ganglia and thalamus. NeuroImage, 38(2), 261-270. https://doi.org/10.1016/j.neuroimage.2007.06.004

Ahmed, I., Bose, S. K., Pavese, N., Ramlackhansingh, A., Turkheimer, F., Hotton, G., Hammers, A. & Brooks, D. J. (2011). Glutamate NMDA receptor dysregulation in Parkinson's disease with dyskinesias. Brain, 134(Pt 4), 979-86. https://doi.org/10.1093/brain/awr028

Aghakhanyan, G., Galgani, A., Vergallo, A., Lombardo, F., Martini, N., Baldacci, F., Tognoni, G., Leo, A., Guidoccio, F., Siciliano, G., Fornai, F., Pavese, N., Volterrani, D. & Giorgi, F. S. (2023). Brain metabolic correlates of Locus Coeruleus degeneration in Alzheimer's disease: a multimodal neuroimaging study. Neurobiology of Aging, 122, 12-21. https://doi.org/10.1016/j.neurobiolaging.2022.11.002

Abrahams, S., Goldstein, L. H., Al-Chalabi, A., Pickering, A., Morris, R. G., Passingham, R. E., Brooks, D. J. & Leigh, P. N. (1997). Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. Journal of Neurology Neurosurgery and Psychiatry, 62(5), 464-472. https://doi.org/10.1136/jnnp.62.5.464

Displaying results 801 to 1000 out of 1007

Revised 01.06.2022

Henriette Blæsild Vuust